1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
2. Brotto, L. A., Abdo, C., Atallah, S., Byers, E. S., Graham, C., Johnson-Agbakwu, C., … Wylie, K. (2015). Committee 2: Psychological and interpersonal dimensions of sexual function and dysfunction in both sexes, ethical and socio-cultural aspects. 4th International Consultation on Sexual Medicine, Madrid, Spain.
3. Cacchioni, T. (2015). Big pharma, women, and the labour of love. Toronto: University of Toronto Press.
4. FDA Briefing Document. (2015). Joint Meeting of the Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management (DSaRM) Advisory Committee on Flibanserin. Retrieved from http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM449088.pdf .
5. Frühauf, S., Gerger, H., Schmidt, H. M., Munder, T., & Barth, J. (2013). Efficacy of psychological interventions for sexual dysfunction: A systematic review and meta-analysis. Archives of Sexual Behavior, 42, 915–933.